ELDN (Eledon Pharmaceuticals) Forward Dividend Yield %: 0.00% (As of Jun. 25, 2026)


ELDN Eledon Pharmaceuticals Inc ELDN
21 GF Score
Price $3.97
! 2 Warning Signs
View Full Analysis

What is Eledon Pharmaceuticals Forward Dividend Yield %?

Eledon Pharmaceuticals ELDN +0.51% 21 Forward Dividend Yield % is 0.00% as of Jun. 25, 2026. GuruFocus rates ELDN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 146 Biotechnology companies, Eledon Pharmaceuticals ranks worse than 684930.82% on this metric.

As of today (2026-06-25), the Forward Annual Dividend Yield of Eledon Pharmaceuticals is 0.00%.

As of today (2026-06-25), the Trailing Annual Dividend Yield of Eledon Pharmaceuticals is 0.00%.

ELDN's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.495
* Ranked among companies with meaningful Forward Dividend Yield % only.

Eledon Pharmaceuticals's Dividends per Share for the three months ended in Mar. 2026 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Eledon Pharmaceuticals  (NAS:ELDN) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Eledon Pharmaceuticals Forward Dividend Yield % Related Terms

ELDN vs ARMP, HUMA, ZNTL: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, Eledon Pharmaceuticals's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eledon Pharmaceuticals Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eledon Pharmaceuticals's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Eledon Pharmaceuticals's Forward Dividend Yield % falls into.


ELDN
21GF Score
Eledon Pharmaceuticals Inc ELDN
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eledon Pharmaceuticals Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Eledon Pharmaceuticals (ELDN) has a Forward Dividend Yield % of 0.00% as of Jun. 25, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Eledon Pharmaceuticals and its competitors. According to the industry distribution chart, Eledon Pharmaceuticals ranks #999999 out of 146 companies in the Biotechnology industry.
Is Eledon Pharmaceuticals' Forward Dividend Yield % too high?
Eledon Pharmaceuticals' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Eledon Pharmaceuticals ranks #999999 out of 146 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Eledon Pharmaceuticals has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Eledon Pharmaceuticals' Forward Dividend Yield % compare to ARMP and HUMA?
According to the Biotechnology industry distribution chart, Eledon Pharmaceuticals ranks #999999 out of 146 companies for Forward Dividend Yield %. This places Eledon Pharmaceuticals in the lower half of its industry. The industry median Forward Dividend Yield % is 1.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.50, based on 146 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Eledon Pharmaceuticals and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eledon Pharmaceuticals's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eledon Pharmaceuticals stock overvalued right now?
Eledon Pharmaceuticals (ELDN) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Eledon Pharmaceuticals' overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Eledon Pharmaceuticals (ELDN), the current Forward Dividend Yield % is 0.00% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eledon Pharmaceuticals Business Description

Other Exchanges 2TK:Germany
Address 19800 MacArthur Boulevard, Suite 250, Irvine, CA, USA, 92612
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
21GF Score

Get the complete analysis for ELDN

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.97
Price